L08.1 Erythrasma

Name of the Condition

• Erythrasma (ICD-10 Code: L08.1)

Summary

Erythrasma is a superficial bacterial skin infection caused by Corynebacterium minutissimum. It typically affects intertriginous areas (skin folds) and presents as well-demarcated, reddish-brown patches. The condition is often asymptomatic but may cause mild itching or burning. It is more common in warm, humid climates and can coexist with fungal infections like tinea cruris.

Causes

Erythrasma is caused by the gram-positive bacterium Corynebacterium minutissimum, which thrives in moist, occluded environments. The infection is not typically transmitted person-to-person but may spread in settings with poor hygiene or shared contaminated items. Overgrowth of this bacterium disrupts the skin's normal flora, leading to the characteristic changes.

Risk Factors

Risk factors include warm, humid climates, obesity, diabetes mellitus, poor hygiene, and occlusive clothing. Intertriginous areas (e.g., groin, axillae, toe webs) are most susceptible due to moisture retention. Immunocompromised individuals or those with chronic skin conditions may also be at increased risk.

Symptoms

Symptoms include well-defined, reddish-brown or scaly patches in skin folds, often with a fine scale. Lesions may be asymptomatic or cause mild itching, burning, or discomfort. The groin, axillae, and toe webs are common sites. Under Wood's lamp examination, lesions may exhibit a characteristic coral-red fluorescence.

Diagnosis

Diagnosis is often clinical, based on the appearance of lesions and their location. A Wood's lamp (ultraviolet light) may reveal coral-red fluorescence, a key diagnostic feature. Skin scrapings or swabs can be cultured to confirm Corynebacterium minutissimum, though this is not always necessary for mild cases.

Treatment Options

Treatment typically involves topical or oral antibiotics. Topical agents like erythromycin or clindamycin are effective for localized cases. For widespread or recurrent infections, oral erythromycin or azithromycin may be prescribed. Antifungal agents are unnecessary unless a concurrent fungal infection is present.

Prognosis and Follow-Up

Prognosis is excellent with appropriate treatment. Lesions usually resolve within weeks. Recurrence is possible, especially in high-risk environments. Follow-up may be recommended to ensure resolution and address underlying risk factors (e.g., hygiene, moisture control).

Complications

Complications are rare but may include secondary bacterial or fungal infections if left untreated. Chronic or severe cases can lead to persistent skin discoloration or discomfort. No systemic complications are typically associated with erythrasma.

Lifestyle & Prevention

Preventive measures include maintaining good hygiene, keeping skin folds dry, and wearing breathable clothing. Weight management and glycemic control (in diabetes) may reduce risk. Avoiding shared personal items (e.g., towels) in communal settings can minimize exposure.

When to Seek Professional Help

Seek care if lesions are painful, spreading, or unresponsive to over-the-counter measures. Persistent or recurrent infections, especially in immunocompromised individuals, warrant evaluation. Consult a healthcare provider if systemic symptoms (e.g., fever) develop.

Tips for Medical Coders

Document the location (e.g., groin, axilla) and clinical findings (e.g., Wood's lamp positivity) to support code assignment. Ensure the diagnosis is clearly differentiated from fungal infections (e.g., tinea cruris) to avoid miscoding. Note any contributing factors like diabetes or obesity, as these may impact coding specificity.